Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Who May Be Eligible (Plain English)

Who May Qualify: Inclusion criteria for patients in Cohort 1 - Age 18 years or older; - completed intravesical treatment for non-muscle invasive bladder cancer within the past year Cohort 1 inclusion criteria for key stakeholders - Age 18 years or older; - experience with the delivery of BCG delivery for more than 2 years Cohort 2 inclusion criteria - Age 18 years or older; - diagnosed with non-muscle invasive bladder cancer and prescribed BCG for initial therapy Who Should NOT Join This Trial: Cohort 1 exclusion criteria • inability to provide willing to sign a consent form Cohort 2 exclusion criteria - inability to provide willing to sign a consent form - inability to undergo catheterization (i.e. - history of urethral stricture) - inability to receive BCG therapy (i.e. - previous reaction with BCG) - no access to mobile phone - inability to respond to written conversations in English Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: Inclusion criteria for patients in Cohort 1 * Age 18 years or older; * completed intravesical treatment for non-muscle invasive bladder cancer within the past year Cohort 1 inclusion criteria for key stakeholders * Age 18 years or older; * experience with the delivery of BCG delivery for more than 2 years Cohort 2 inclusion criteria * Age 18 years or older; * diagnosed with non-muscle invasive bladder cancer and prescribed BCG for initial therapy Exclusion Criteria: Cohort 1 exclusion criteria • inability to provide informed consent Cohort 2 exclusion criteria * inability to provide informed consent * inability to undergo catheterization (i.e. - history of urethral stricture) * inability to receive BCG therapy (i.e. - previous reaction with BCG) * no access to mobile phone * inability to respond to written conversations in English

Treatments Being Tested

OTHER

BCG delivery at home

The BCG at home project will be a single-arm prospective pilot, to evaluate the feasibility, scalability and effectiveness of home treatment, and utilize the BB-Bot (chatbot) for PRO and adverse event measurement.

Locations (1)

Abramson Cancer Center
Philadelphia, Pennsylvania, United States